Also known as: Germanin / Bayer 205
Suramin is a polysulfonated naphthylurea compound with antiparasitic and antineoplastic properties. Originally developed for African sleeping sickness (Human African Trypanosomiasis), Suramin has gained renewed research interest as an ectoenzyme inhibitor, anti-cancer agent, and has been investigated for autism spectrum disorder and COVID-19. Mediocon Inc supplies high-purity Suramin API from its GMP-certified manufacturing facility in Maharashtra, India.
| Parameter | Specification |
|---|---|
| CAS Number | 145-63-1 |
| Molecular Formula | C₅₁H₄₀N₆O₂₃S₆ |
| Molecular Weight | 1297.28 g/mol |
| Grade | IP / BP / USP |
| Category | Antiparasitic / Antineoplastic |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Suramin — CAS 145-63-1 (CAS 145-63-1) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Suramin — CAS 145-63-1 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance